1-3 of 3
Michael Hamilton
Close
Sort by
Journal Articles

In Vitro Characterization of Wnt/β-Catenin Pathway Inhibition in Multiple Myeloma Cell Lines Using a Novel Class of Small Molecules.

Jeffrey W. Strovel, PhD, Tammy Lawrence, B.S., Pachai Natarajan, M.S., Stephen Glanowski, Ph.D., Irina Lonskaya, Ph.D., Zoe Weaver, Ph.D., Janka Padia, Ph.D., Jeffrey W. Watthey, Ph.D., Wieslaw M. Cholody, Ph.D., J. Michael Hamilton, M.D., David K. Bol, Ph.D., Stephen K. Horrigan, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2523.
https://doi.org/10.1182/blood.V110.11.2523.2523
Published: 2007
Journal Articles

Clinical-Biomarker Correlations in Adult AML Patients in a Phase I Trial of AVN944 Support Observations of Clinical Effect and Provide Hypotheses for Patient Selection Criteria for Further Clinical Trials.

Rebecca B. Klisovic, MD, Steven Coutre, MD, Tibor J. Kovacsovics, MD, Hagop M. Kantarjiam, MD, Guido J. Tricot, MD, Jeffrey W. Strovel, PhD, Thomas Genna, RhP, David K. Bol, PhD, Michael Hamilton, MD, Beverly S. Mitchell, MD
Journal: Blood
Blood (2007) 110 (11): 896.
https://doi.org/10.1182/blood.V110.11.896.896
Published: 2007
Journal Articles

Assessment of Bleeding in Thrombocytopenic Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

Lemke K. Page, MD, Andrew S. Elish, Drew Provan, MD, Steven Myrint, MD, Michael Hamilton, MD, Julian Jenkins, MS, James B. Bussel, MD
Journal: Blood
Blood (2005) 106 (11): 1255.
https://doi.org/10.1182/blood.V106.11.1255.1255
Published: 2005